Completely agree, “I’ll Drink”.
We also have:
- Lessons from the previous trials eg we have a better idea of how many capsules of NTCELL to use (80)
- AI technology
- Access to a new CT scanner to observe any changes to the brain
- Much better management compared with the start of last year. They are meeting their deadlines and communicating regularly with SH's.
Ann: Preliminary Final Report and 2022 Financial Statements, page-5
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $21.44K | 3.049M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 6215793 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 552894 | 2 |
View Market Depth
| Last trade - 15.38pm 02/10/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |